Company Filing History:
Years Active: 2022-2025
Title: Craig Stephen Buxton: Innovator in Respiratory Disease Treatment
Introduction
Craig Stephen Buxton is a notable inventor based in Didcot, GB. He has made significant contributions to the field of respiratory disease treatment through his innovative work. With a total of 2 patents, Buxton is recognized for his advancements in the modulation of calcium-activated chloride channels.
Latest Patents
Buxton's latest patents focus on compounds that serve as positive modulators of the calcium-activated chloride channel (CaCC), specifically TMEM16A. These compounds are designed to treat diseases and conditions that are influenced by the modulation of TMEM16A, particularly respiratory diseases. The compounds are defined by a general formula that includes various components, which are crucial for their effectiveness in medical applications.
Career Highlights
Craig Stephen Buxton is associated with Tmem16a Limited, where he continues to develop innovative solutions for respiratory health. His work is characterized by a commitment to improving treatment options for patients suffering from respiratory conditions.
Collaborations
Buxton collaborates with notable colleagues, including Stephen Collingwood and Clive McCarthy, to further enhance the impact of his inventions in the medical field.
Conclusion
Craig Stephen Buxton's contributions to the treatment of respiratory diseases through his patented compounds highlight his role as an influential inventor. His ongoing work promises to advance the understanding and management of respiratory conditions, ultimately benefiting many patients.